LLY
Eli Lilly and Company
LLY's fundamentals are strong: revenue grew 46% and it turned 23% of its revenue into free cash flow. At 46x earnings, it's trading in line with its usual 48x. Analysts expect that strong growth to continue.
RDGT
Ridgetech Inc.
There isn't enough reported data to score RDGT yet.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
RDGT Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| Unavailable | |
| Strong |
RDGT's profitability and balance sheet are currently healthy. There isn't enough data to rate its revenue and cash flow.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
RDGT PE Valuation
RDGT has no meaningful PE right now: it lost money over the past year.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for LLY, with profitability improving.
RDGT Forward outlook
There aren't enough analyst estimates for RDGT to show an outlook.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY has the stronger earnings trend. Trailing diluted EPS is up 51% for LLY versus RDGT down 100%.
RDGT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q1 2021 | -$1,098,000.00 | -$132,750.00 |
| Q4 2020 | -$1,559,250.00 | -1185% |
| Q3 2020 | -$641,250.00 | -$353,025.00 |
| Q2 2020 | -$641,250.00 | -$245,025.00 |
| Q1 2020 | -$965,250.00 | -$839,025.00 |
| Q4 2019 | $143,775.00 | +$3,460,500.00 |
| Q3 2019 | -$288,225.00 | +$3,136,500.00 |
| Q2 2019 | -$396,225.00 | +$2,974,500.00 |
RDGT has returned to profit: it earned $276.00 per share over the past year, after losing money the year before.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY has the stronger quarterly revenue trend. Revenue is up 39% for LLY versus down 8.7% for RDGT.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY's operating margin was 34% last quarter, down 6.6 points from the same quarter a year ago.
RDGT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $69.4M | -42% |
| Q3 2025 | $62.8M | -12% |
| Q1 2025 | $120M | +58% |
| Q3 2024 | $71.2M | -9.4% |
| Q1 2024 | $76M | -49% |
| Q1 2023 | $148.8M | -9.5% |
| Q1 2022 | $164.4M | +360% |
| Q1 2021 | $35.7M | +18% |
RDGT's revenue has slid since its 2022 peak: $69M last quarter, down 8.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q1 2026 | -2.6% | +2.4 points |
| Q3 2025 | -0.1% | -0.5 points |
| Q1 2025 | -0.9% | +13 points |
| Q3 2024 | -3.1% | -1.5 points |
| Q1 2024 | -5% | -3.5 points |
| Q3 2023 | 0.3% | +18 points |
| Q1 2023 | -14% | -9.1 points |
| Q1 2022 | -1.6% | -0.3 points |
RDGT's operating margin was −2.6% last quarter, up 2.4 points from the same quarter a year ago.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the stronger cash trend. Its trailing FCF is up 259% versus its history, compared with RDGT at down 77%.
RDGT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2025 | $1.1M | +$5.3M |
| Q3 2024 | -$10.1M | -1517% |
| Q1 2024 | -$4.2M | -$797.7K |
| Q1 2023 | -$3.4M | +$2.1M |
| Q1 2022 | -$5.5M | -145% |
| Q1 2021 | $12.1M | +219% |
| Q4 2020 | -$12.1M | +$387.3K |
| Q3 2020 | $5M | -44% |
RDGT's free cash flow was −$13M over the past year, against −$9M the year before.
LLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -300K shares |
| 1 year | -0.6% | -5.4M shares |
| 3 years | -0.7% | -6.4M shares |
| 5 years | -1.9% | -17.4M shares |
| Available history | -4.5% | -42.3M shares |
LLY has the edge over RDGT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $377M |
| Q2 2026 | $1.6B |
| Q1 2026 | $2.4B |
| Q4 2025 | $1.5B |
| Q3 2025 | $708.1M |
| Q2 2025 | $692.2M |
| Q1 2025 | $1.2B |
| Q4 2024 | $2.1B |
LLY spent $5.8B buying back its own shares over the past year, up 26% from the year before.
RDGT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +5.6% | +2.1K shares |
| 1 year | +1048% | +35.6K shares |
| 3 years | +650450% | +39K shares |
| 5 years | +780560% | +39K shares |
| Available history | +1301000% | +39K shares |
RDGT has 39,033 diluted shares, up 1048% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
| Q4 2019 | — |
| Q3 2019 | — |
| Q2 2019 | — |
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.
RDGT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2025 | -23.5x | Net Cash |
| Q1 2019 | 20.8x | High |
| Q3 2016 | 3.2x | Elevated |
RDGT has more cash than debt.
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
RDGT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.8 | Neutral |
| Stochastic | 28.7 | Neutral |
RDGT's weekly RSI is 35 (neutral) and its Stochastic is 29 (neutral).
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
RDGT PE vs Healthcare Sector
| Metric | RDGT | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
RDGT has no meaningful PE right now: it lost money over the past year.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY has the edge over RDGT on trend strength, trading above more of its moving averages.
RDGT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.91 | 22% above |
| 20 week MA | $0.99 | 12% above |
| 50 week MA | $122.2 | 99% below |
| 100 week MA | $171.8 | 99% below |
| 200 week MA | $1,289.0 | 100% below |
RDGT has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 100% below its 200-week average.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has the edge over RDGT on returns for 2026, with the stronger performance.
RDGT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $66,240.0 | $37,080.0 | -44% |
| 2021 | $37,080.0 | $14,047.6 | -62% |
| 2022 | $14,047.6 | $11,850.0 | -16% |
| 2023 | $11,850.0 | $666.0 | -94% |
| 2024 | $666.0 | $271.5 | -59% |
| 2025 | $271.5 | $483.0 | +78% |
| 2026 YTD | $483.0 | $1.11 | -100% |
RDGT has finished lower in five of the last six years. It's down 100% so far in 2026.